Oscar Health, Inc. Announces that Mark Bertolini’s Foundation Purchases Shares of Oscar Health

Rhea-AI Summary

Oscar Health (NYSE: OSCR) announced that the Anahata Foundation, established by CEO Mark T. Bertolini, purchased 933,333 shares on the open market during the week of November 11, 2024. The company was not involved in these transactions. Bertolini expressed confidence in Oscar's future, highlighting the company's talent, products, and technology as key factors in transforming healthcare, particularly in making the individual market a preferred choice for Americans.

Positive

• CEO's foundation makes significant share purchase of 933,333 shares, demonstrating insider confidence
• Strong vote of confidence from CEO in company's growth prospects and market position

Negative

• None.

Insights

Financial Analyst

The CEO's foundation purchasing 933,333 shares represents a significant insider transaction and vote of confidence in Oscar Health's future. With the stock trading at approximately $15 per share, this represents a roughly $14 million investment. Insider purchases of this magnitude typically signal management's strong belief in the company's growth prospects and current valuation. The healthcare technology sector has faced challenges, making this substantial commitment particularly noteworthy. The transaction strengthens market confidence in Oscar's strategy to transform the individual health insurance market. However, investors should note that foundation purchases, while positive signals, may have different motivations than direct personal investments.

NEW YORK--(BUSINESS WIRE)-- Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, today announced that the Anahata Foundation (“Anahata”), a charitable foundation established by Mark T. Bertolini, Oscar’s Chief Executive Officer, purchased 933,333 shares on the open market the week of November 11, 2024. Oscar was not a party to any of these transactions.

Bertolini said: “I believe in the future of Oscar. I am convinced Oscar is the company with the talent, products, and technology to change healthcare. The future is bright. My continued investment in Oscar reiterates my confidence in our growth, in the team, and in our opportunity to make the individual market the chosen solutions for all Americans.”

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained herein are forward-looking statements. These statements include, but are not limited to, statements about our financial outlook, our profitability goals, our business and financial prospects, including potential future growth of the markets Oscar serves, and our management’s plans and objectives for future operations, expectations and business strategy. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “targets,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of these terms or other similar expressions. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions, and uncertainties that are difficult to predict and generally beyond our control.

Although we believe that the expectations reflected in these forward-looking statements are reasonable as of the date made, there are or will be important factors that could cause our actual results to differ materially from those indicated in these forward-looking statements, including, but not limited to, the following: our ability to execute our strategy and manage our growth effectively; our ability to retain and expand our member base; heightened competition in the markets in which we participate; our ability to accurately estimate our incurred medical expenses or effectively manage our medical costs or related administrative costs; our ability to achieve or maintain profitability in the future; changes in federal or state laws or regulations, including changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010, as amended (collectively, the “ACA”), and any regulations enacted thereunder; our ability to comply with ongoing regulatory requirements, including capital reserve and surplus requirements and applicable performance standards; changes or developments in the health insurance markets in the United States, including passage and implementation of a law to create a single-payer or government-run health insurance program; our, or any of our vendors’, ability to comply with laws, regulations, and standards related to the handling of information about individuals or applicable consumer protection laws; our ability to arrange for the delivery of quality care and maintain good relations with the physicians, hospitals, and other providers within and outside our provider networks; unanticipated results of, or changes to, risk adjustment programs; our ability to utilize quota share reinsurance to meet our capital and surplus requirements and protect against downside risk on medical claims; unfavorable or otherwise costly outcomes of lawsuits, audits, investigations, and claims that arise from the extensive laws and regulations to which we are subject; incurrence of data security breaches of our and our partners’ information and technology systems; our ability to attract and retain qualified personnel; our ability to detect and prevent material weaknesses or significant control deficiencies in our internal controls over financial reporting or other failure to maintain an effective system of internal controls; adverse publicity or other adverse consequences related to our dual class structure or “controlled company” status; and the other factors set forth under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the Securities and Exchange Commission (“SEC”), as any such factors may be updated from time to time in our other filings with the SEC, including without limitation our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2024, with the SEC.

You are cautioned not to place undue reliance on any forward-looking statements made in this press release. Any forward-looking statement speaks only as of the date as of which it is made, and, except as otherwise required by law, we do not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise. New factors emerge from time to time, and it is not possible for us to predict which will arise.

About Oscar Health

Oscar Health, Inc. (“Oscar”) is a leading healthcare technology company built around a full stack technology platform and a relentless focus on serving our members. We have been challenging the status quo in the healthcare system since our founding in 2012, and are dedicated to making a healthier life accessible and affordable for all. Oscar offers Individual & Family plans and health technology solutions that power the healthcare industry through +Oscar. Our technology drives superior experiences, deep engagement, and high-value clinical care, earning us the trust of approximately 1.65 million members, as of September 30, 2024.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241118714461/en/

Investor Contact:

Chris Potochar

VP of Investor Relations

ir@hioscar.com

Media Contact:

Kristen Prestano

VP of Communications

press@hioscar.com

Source: Oscar Health, Inc.

FAQ

How many shares did Mark Bertolini's Anahata Foundation purchase of Oscar Health (OSCR) in November 2024?

The Anahata Foundation purchased 933,333 shares of Oscar Health (OSCR) on the open market during the week of November 11, 2024.

Was Oscar Health (OSCR) involved in the November 2024 share purchase by the Anahata Foundation?

No, Oscar Health (OSCR) was not a party to any of these share purchase transactions.

What was the purpose of Anahata Foundation's share purchase of Oscar Health (OSCR)?

The purchase demonstrated CEO Mark Bertolini's confidence in Oscar's growth potential, team capabilities, and mission to transform healthcare through its talent, products, and technology.